NanoViricides
NNVC
#10399
Rank
A$56.22 M
Marketcap
A$2.20
Share price
1.97%
Change (1 day)
-10.21%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: A$56.22 Million

As of August 2026 NanoViricides has a market cap of A$56.22 Million. This makes NanoViricides the world's 10399th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$56.22 M46.72%
2025A$38.31 M10.75%
2024A$34.59 M96.75%
2023A$17.58 M-7.14%
2022A$18.93 M-67.98%
2021A$59.13 M48.56%
2020A$39.8 M186.87%
2019A$13.87 M-29.68%
2018A$19.73 M-72.36%
2017A$71.39 M-17.36%
2016A$86.39 M-7.75%
2015A$93.66 M-50.18%
2014A$0.18 B-30.19%
2013A$0.26 B274.01%
2012A$72 M-18.96%
2011A$88.84 M-55.77%
2010A$0.20 B60.92%
2009A$0.12 B-11.4%
2008A$0.14 B165.05%
2007A$53.15 M

End of Day market cap according to different sources

On Aug 3rd, 2026 the market cap of NanoViricides was reported to be:

A$55.46 Million
by Nasdaq info icon info icon
A$56.22 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$231.62 B 411,885.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$448.89 B 798,331.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$190.24 B 338,270.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$146.75 B 260,919.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.73 B 2,982.93%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$3.18 B 5,565.39%๐Ÿ‡บ๐Ÿ‡ธ USA